Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anti-PD-1 MAb industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Beijing Beigene
Merck
Junshi Pharma
Innovent Biologics Inc
Hengrui Medicine
Bristol Myers Squibb
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
40mg
100mg
200mg
Others
Application:
Melanoma Patients
Lung Cancer Patients
Lymphoma Patients
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Anti-PD-1 MAb Industry Overview
-
1.1.1 Anti-PD-1 MAb Market Scope and Market Segments
-
1.1.2 Anti-PD-1 MAb Industry Characteristics
-
1.1.3 Global and China Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Anti-PD-1 MAb Production Value and Growth Rate (2017-2028)
-
1.2 Global Anti-PD-1 MAb Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 40mg
-
1.2.2 100mg
-
1.2.3 200mg
-
1.2.4 Others
-
1.3 Global Anti-PD-1 MAb Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Melanoma Patients
-
1.3.2 Lung Cancer Patients
-
1.3.3 Lymphoma Patients
-
1.3.4 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Anti-PD-1 MAb Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Anti-PD-1 MAb Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Anti-PD-1 MAb Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Anti-PD-1 MAb Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Anti-PD-1 MAb Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Anti-PD-1 MAb Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Anti-PD-1 MAb Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Anti-PD-1 MAb Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Anti-PD-1 MAb Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Anti-PD-1 MAb Industry Porter's Five Forces Model Analysis
-
2.2.3 Anti-PD-1 MAb Industry PEST Analysis
-
2.3 Anti-PD-1 MAb Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Anti-PD-1 MAb Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Anti-PD-1 MAb Industry
Chapter 3 Global and China Anti-PD-1 MAb Market, by Manufacturer
-
3.1 Global and China Anti-PD-1 MAb Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Anti-PD-1 MAb Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Anti-PD-1 MAb Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Anti-PD-1 MAb Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Anti-PD-1 MAb Market Top 3 Players
Chapter 4 Global and China Anti-PD-1 MAb Market, by Type (2017-2028)
-
4.1 Anti-PD-1 MAb Market Trend, by Type
-
4.2 Global Anti-PD-1 MAb Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Anti-PD-1 MAb Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Anti-PD-1 MAb Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Anti-PD-1 MAb Price Trend, by Type (2017-2028)
-
4.3 China Anti-PD-1 MAb Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Anti-PD-1 MAb Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Anti-PD-1 MAb Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Anti-PD-1 MAb Price Trend, by Type (2017-2028)
Chapter 5 Global and China Anti-PD-1 MAb Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Anti-PD-1 MAb Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Anti-PD-1 MAb Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Anti-PD-1 MAb Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Anti-PD-1 MAb Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Anti-PD-1 MAb Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Anti-PD-1 MAb Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Anti-PD-1 MAb Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Anti-PD-1 MAb Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Anti-PD-1 MAb Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Anti-PD-1 MAb Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Anti-PD-1 MAb Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Anti-PD-1 MAb Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Anti-PD-1 MAb Market Analysis
-
7.1 North America Anti-PD-1 MAb Market, by Type
-
7.2 North America Anti-PD-1 MAb Market, by Application
-
7.3 North America Anti-PD-1 MAb Market Analysis and Forecast, by Country
-
7.3.1 United States Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Anti-PD-1 MAb Market Analysis
-
8.1 Europe Anti-PD-1 MAb Market, by Type
-
8.2 Europe Anti-PD-1 MAb Market, by Application
-
8.3 Europe Anti-PD-1 MAb Market Analysis and Forecast, by Country
-
8.3.1 Germany Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Anti-PD-1 MAb Market Analysis
-
9.1 APAC Anti-PD-1 MAb Market, by Type
-
9.2 APAC Anti-PD-1 MAb Market, by Application
-
9.3 APAC Anti-PD-1 MAb Market Analysis and Forecast, by Country
-
9.3.1 China Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Anti-PD-1 MAb Market Analysis
-
10.1 Latin America, Middle East and Africa Anti-PD-1 MAb Market, by Type
-
10.2 Latin America, Middle East and Africa Anti-PD-1 MAb Market, by Application
-
10.3 Latin America, Middle East and Africa Anti-PD-1 MAb Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Anti-PD-1 MAb Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Anti-PD-1 MAb Company Profiles
-
11.1 Beijing Beigene
-
11.1.1 Beijing Beigene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Beijing Beigene Anti-PD-1 MAb Product Profiles, Application and Specification
-
11.1.3 Beijing Beigene Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Merck
-
11.2.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Merck Anti-PD-1 MAb Product Profiles, Application and Specification
-
11.2.3 Merck Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Junshi Pharma
-
11.3.1 Junshi Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Junshi Pharma Anti-PD-1 MAb Product Profiles, Application and Specification
-
11.3.3 Junshi Pharma Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Innovent Biologics Inc
-
11.4.1 Innovent Biologics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Innovent Biologics Inc Anti-PD-1 MAb Product Profiles, Application and Specification
-
11.4.3 Innovent Biologics Inc Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Hengrui Medicine
-
11.5.1 Hengrui Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Hengrui Medicine Anti-PD-1 MAb Product Profiles, Application and Specification
-
11.5.3 Hengrui Medicine Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Bristol Myers Squibb
-
11.6.1 Bristol Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Bristol Myers Squibb Anti-PD-1 MAb Product Profiles, Application and Specification
-
11.6.3 Bristol Myers Squibb Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Anti-PD-1 MAb Industry Investment Prospect and Risk Assessment
-
12.1 Anti-PD-1 MAb Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Anti-PD-1 MAb Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Global Anti-PD-1 MAb Production Value and Growth Rate (2017-2028)
-
Figure China Anti-PD-1 MAb Production Value and Growth Rate (2017-2028)
-
Figure Global Anti-PD-1 MAb Market Size and Growth Rate of 40mg (2017-2028)
-
Figure Global Anti-PD-1 MAb Market Size and Growth Rate of 100mg (2017-2028)
-
Figure Global Anti-PD-1 MAb Market Size and Growth Rate of 200mg (2017-2028)
-
Figure Global Anti-PD-1 MAb Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Anti-PD-1 MAb Market Size and Growth Rate of Melanoma Patients (2017-2028)
-
Figure Global Anti-PD-1 MAb Market Size and Growth Rate of Lung Cancer Patients (2017-2028)
-
Figure Global Anti-PD-1 MAb Market Size and Growth Rate of Lymphoma Patients (2017-2028)
-
Figure Global Anti-PD-1 MAb Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Anti-PD-1 MAb Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Anti-PD-1 MAb Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Anti-PD-1 MAb Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-PD-1 MAb Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Anti-PD-1 MAb Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Anti-PD-1 MAb Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Anti-PD-1 MAb Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Anti-PD-1 MAb Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Anti-PD-1 MAb Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Anti-PD-1 MAb Market Share, by Manufacturer in 2021
-
Figure Global and China Anti-PD-1 MAb Market Share, by Manufacturer in 2022
-
Table Global Anti-PD-1 MAb Sales Volume, by Type (2017-2028)
-
Table Global Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Figure Global Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Table Global Anti-PD-1 MAb Sales Value, by Type (2017-2028)
-
Table Global Anti-PD-1 MAb Sales Value Share, by Type (2017-2028)
-
Figure Global Anti-PD-1 MAb Price Trend, by Type (2017-2028)
-
Table China Anti-PD-1 MAb Sales Volume, by Type (2017-2028)
-
Table China Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Figure China Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Table China Anti-PD-1 MAb Sales Value, by Type (2017-2028)
-
Table China Anti-PD-1 MAb Sales Value Share, by Type (2017-2028)
-
Figure China Anti-PD-1 MAb Price Trend, by Type (2017-2028)
-
Table Global Anti-PD-1 MAb Sales Volume, by Application (2017-2028)
-
Table Global Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Figure Global Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Table Global Anti-PD-1 MAb Sales Value, by Application (2017-2028)
-
Table Global Anti-PD-1 MAb Sales Value Share, by Application (2017-2028)
-
Figure Global Anti-PD-1 MAb Sales Value Share, by Application (2017-2028)
-
Table China Anti-PD-1 MAb Sales Volume, by Application (2017-2028)
-
Table China Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Table China Anti-PD-1 MAb Sales Value, by Application (2017-2028)
-
Table China Anti-PD-1 MAb Sales Value Share, by Application (2017-2028)
-
Figure China Anti-PD-1 MAb Sales Value Share, by Application (2017-2028)
-
Figure China Anti-PD-1 MAb Production, Import, Consumption and Export (2017-2022)
-
Figure North America Anti-PD-1 MAb Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Anti-PD-1 MAb Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Anti-PD-1 MAb Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Anti-PD-1 MAb Production, Import, Consumption and Export (2017-2022)
-
Table North America Anti-PD-1 MAb Sales Volume, by Type (2017-2028)
-
Table North America Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Figure North America Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Table North America Anti-PD-1 MAb Sales Volume, by Application (2017-2028)
-
Table North America Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Figure North America Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Figure United States Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure United States Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Canada Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Table Europe Anti-PD-1 MAb Sales Volume, by Type (2017-2028)
-
Table Europe Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Figure Europe Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Table Europe Anti-PD-1 MAb Sales Volume, by Application (2017-2028)
-
Table Europe Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Figure Europe Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Figure Germany Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure UK Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure UK Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure France Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure France Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Italy Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Spain Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Poland Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Russia Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Table APAC Anti-PD-1 MAb Sales Volume, by Type (2017-2028)
-
Table APAC Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Figure APAC Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Table APAC Anti-PD-1 MAb Sales Volume, by Application (2017-2028)
-
Table APAC Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Figure APAC Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Figure China Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure China Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Japan Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure India Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure India Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Anti-PD-1 MAb Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-PD-1 MAb Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Anti-PD-1 MAb Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Anti-PD-1 MAb Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Anti-PD-1 MAb Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Anti-PD-1 MAb Sales Value and Growth Rate (2017-2028)
-
Table Beijing Beigene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Beijing Beigene Product Profiles, Application and Specification
-
Table Beijing Beigene Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Junshi Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Junshi Pharma Product Profiles, Application and Specification
-
Table Junshi Pharma Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Innovent Biologics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Innovent Biologics Inc Product Profiles, Application and Specification
-
Table Innovent Biologics Inc Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Hengrui Medicine Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Hengrui Medicine Product Profiles, Application and Specification
-
Table Hengrui Medicine Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol Myers Squibb Product Profiles, Application and Specification
-
Table Bristol Myers Squibb Anti-PD-1 MAb Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
